ArticleFrontiers in pharmacology2020

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.

Vincenzo Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.